Yayınlar & Eserler

Yayın Ağı
Makaleler 16
Tümü (16)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (15)
Scopus (14)
TRDizin (1)

1. Comparison of 6 cycles with 4 cycles of chemotherapy and atezolizumab in the first-line treatment of ES-SCLC: a retrospective multicenter analysis

Güzel H. G., Kıvrak Salim D., Kılıçkap S., Kemal Y., Akosman C., Köseoğlu Ç., et al.
Oncologist , cilt.31, sa.4, 2026 (SCI-Expanded, Scopus) identifier identifier

2. Serum Vitamin D Levels as a Prognostic Biomarker in Patients Receiving Immune Checkpoint Inhibitors

Şahi̇n T. K., BAŞ O., KAVGACI G., Güdük N., ŞİRVAN F., AKIN S., et al.
Journal of Oncological Science , cilt.12, sa.1, ss.1-8, 2026 (Scopus, TRDizin) Creative Commons License identifier

3. Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors

BAŞ O., Tokatli M., Savkliyildiz M., Yazarkan Y., Guduk N., Kilinc C., et al.
EXPERT REVIEW OF ANTICANCER THERAPY , sa.4, ss.405-409, 2025 (SCI-Expanded) identifier identifier

4. Clinical Characteristics and Management of Patients Admitted to the Supportive Care Clinic and Predisposing Factors of Unplanned Hospital Readmission: Single-Center Experience

BAŞ O., Tokatli M., Guduk N., Erdogan D., Boyraz N. E., Cengelci C., et al.
JOURNAL OF CLINICAL MEDICINE , sa.8, 2025 (SCI-Expanded, Scopus) identifier identifier

5. Serum Albumin-Creatinine Ratio and Anthracycline Cardiotoxicity in Patients with Cancer

BAŞ O., Guduk N., Tokatli M., Guven D. C., ÖZER N., ŞENER Y. Z., et al.
JOURNAL OF CLINICAL MEDICINE , sa.5, 2025 (SCI-Expanded, Scopus) identifier identifier

6. The association between HALP score and survival in patients treated with immune checkpoint inhibitors

ŞAHİN T. K., GÜVEN D. C., Durukan M., BAŞ O., KAYGUSUZ Y., ARIK Z., et al.
EXPERT REVIEW OF ANTICANCER THERAPY , sa.1, ss.81-89, 2025 (SCI-Expanded) identifier identifier

7. Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study

Majidova N., Arak H., ÖZALP F. R., BAŞ O., ÖZÇELİK KÖKER G., Ozmarasali E. B., et al.
SCIENTIFIC REPORTS , sa.1, 2025 (SCI-Expanded, Scopus) identifier identifier

8. Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma

Demir T., Araz M., Moloney C., Hendem E., Kocak M. Z., ERMAN M., et al.
CLINICAL LUNG CANCER , sa.7, 2024 (SCI-Expanded, Scopus) identifier

9. Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study

KUTLU Y., Dae S. A., YILMAZ F., Erdem D., Sendur M. A. N., Akbas S., et al.
CANCERS , cilt.16, sa.12, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

10. Infectious complications of cyclin-dependent kinases 4 and 6 inhibitors in patients with hormone-receptor-positive metastatic breast cancer: a systematic review and meta-analysis

BAŞ O., Erul E., GÜVEN D. C., AKSOY S.
SUPPORTIVE CARE IN CANCER , cilt.30, sa.11, ss.9071-9078, 2022 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma identifier identifier identifier

11. Adjuvant treatment with paclitaxel plus trastuzumab for node-negative breast cancer: real-life experience

Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., TABAN H., et al.
FUTURE ONCOLOGY , cilt.18, ss.323-331, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

12. Sarcopenia and anthracycline cardiotoxicity in patients with cancer

BAŞ O., ERDEMİR A. G., ONUR M. R., ÖZER N., ŞENER Y. Z., AKSU S., et al.
BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

13. Chemoimmunotherapy for the salvage treatment of Ewing sarcoma: A case report

GÜVEN D. C., KILIÇKAP S., YILDIRIM H. Ç., Ceylan F., BAŞ O., DİZDAR Ö.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.5, ss.1281-1283, 2021 (SCI-Expanded, Scopus) identifier identifier identifier

14. Adjuvant treatment with paclitaxel plus trastuzumab for node negative human epidermal growth factor receptor 2-positive breast cancer: Real life experience

Diker O., AKTAŞ B. Y., Ak R., KÖYLÜ B., BAŞ O., Olgun P., et al.
CANCER RESEARCH , cilt.81, sa.4, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier

15. Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma

BAŞ O., Ozbek A., Guven D., Aktepe O., KILIÇ L., KERTMEN N., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.26, sa.5, ss.1230-1233, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

16. Classifying sarcopenia: using median value or cut-off values?

BAŞ O., DİZDAR Ö.
BREAST CANCER RESEARCH AND TREATMENT , cilt.176, sa.2, ss.479, 2019 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 2

1. Efficacy of systemic treatments in patients with metastatic lung invasive mucinous adenocarcinoma

Demir T., Araz M., Hendem E., Kocak M. Z., Erman M., Bas O., et al.
Special Clinical Science Symposia, ELECTR NETWORK, 29 Mayıs 2024, (Özet Bildiri) identifier

2. GEBELİK ESNASINDA ORTAYA ÇIKAN GİTELMANSENDROMU

BAŞ O., ÇALIK BAŞARAN N., KÜKNER S., ÖZIŞIK L., ÖZ Ş. G., ARICI M.
20. Ulusal iç Hastalıkları Kongresi, Antalya, Türkiye, 10 - 14 Ekim 2018, (Özet Bildiri)
Metrikler

Yayın

18

Yayın (WoS)

16

Yayın (Scopus)

14

Atıf (WoS)

8

H-İndeks (WoS)

1

Atıf (Scopus)

3

H-İndeks (Scopus)

1

Proje

1

Açık Erişim

4
BM Sürdürülebilir Kalkınma Amaçları